Biotech Values

[jq1234]

Novo Nordisk Raises 2011 Sales, Profit Forecasts on Higher Victoza Revenue

http://www.bloomberg.com/news/2011-08-04/novo-nordisk-raises-2011-sales-profit-forecasts-on-higher-victoza-revenue.html

Novo Nordisk increased operating profit by 13% in the first six
months of 2011
Sales growth of 11% in local currencies driven by Victoza®, NovoRapid® and
Levemir®

http://www.novonordisk.com/include/asp/exe_news_attachment.pdf?sAttachmentGUID=2b135b44-0b47-4085-b4a5-a90e974c0c1d